European Archives - Page 176 of 900 - European Medical Journal

EMJ

Understanding the role of predictive biomarkers in guiding the treatment of patients with endometrial cancer

This episode discusses key findings from recent research into predictive biomarkers in endometrial cancer, specifically focusing on the potential for these biomarkers to inform clinical decision making.

EULAR 2023 Abstract Highlights

The following selected highlights spotlight several interesting and timely abstracts presented at the European Alliance of Associations…

European Alliance of Associations for Rheumatology (EULAR) Congress 2023: Take-Home Messages from an Excellent Congress

The congress covered all topics of Rheumatology. During the opening plenary session, Annamaria Iagnocco, European Alliance of Associations…

EMJ Rheumatology 10.1 2023

We are excited to announce the latest issue of EMJ Rheumatology, including a review of the European Alliance of Associations for Rheumatology (EULAR) 2023 Congress, highlighting key sessions from the event.

Prevalence of Risk for Anxiety and Depression in Patients with Rheumatic Diseases

There is a higher prevalence of anxiety and depression in patients with chronic diseases. In a complex relationship, chronic diseases and…

Work Participation and the COVID-19 Pandemic: A Study Within the Amsterdam COVID-19 Cohort Among People with Inflammatory Rheumatic Diseases and Population Controls

Past research has repeatedly shown that patients with inflammatory rheumatic disease (IRD) experience restrictions in work participation.

Predictors of Renal Flares in Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a highly heterogenous clinical presentation that can affect…

Interactive Study on Diagnosis and Management of Endometrial Cancer

This interactive study describes the incidence, epidemiology, diagnosis, staging, and risk assessment of endometrial cancer, and…

Are Myosin Inhibitors the Future of HCM Management?

This podcast episode explores new advances in treating obstructive hypertrophic cardiomyopathy (HCM) and the role of myosin inhibitors.

Evolving the treatment paradigm in cold agglutinin disease (CAD): Challenges and opportunities for optimal management

Prof. Alexander Röth (Chair), Prof. Wilma Barcellini, Prof. Josephine Vos and Prof. Bernd Jilma, will discuss about the evolving treatment paradigm in cold agglutinin disease (CAD): challenges and opportunities for optimal management.